FindTrial
Sign In

Application of ERAS in cardiovascular surgery

Application of ERAS in cardiovascular surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800018167
Enrollment
Unknown
Registered
2018-09-03
Start date
2018-01-01
Completion date
Unknown
Last updated
2018-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cardiovascular diseases

Interventions

Respiratory exercise group:Respiratory exercise
acupuncture:acupuncture
Video visitation group:Video visitation
Leosimendan:Leosimendan
tirofiban:tirofiban
esmolol:esmolol
Improved extracorporeal circulation perfusion:Improved extracorporeal circulation perfusion
early ambulation group:early ambulation

Sponsors

Shandong Provincial Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. aged>18 years; 2. undergoing cardiocvascular surgery; 3. willingness to provide informed consent

Exclusion criteria

Exclusion criteria: 1. cardiac function level; 2. severe arrhythmias; 3. history of psychiatric disorders (schizophrenia, mania, psychosis); 4. allergic to drugs; 5. can not afford rehabilitation.

Design outcomes

Primary

MeasureTime frame
CTNI;arterial blood gas analysis;HR;BP;anxiety;—

Secondary

MeasureTime frame
HRV;Tracheal intubation time;Leosimendan blood concentration;Leosimendan metabolite;cardiac output;CVP;30 days mortality;complication;delirium;—

Countries

China

Contacts

Public ContactQi Tan

Shandong Provincial Hospital

81453381@QQ.COM+86 18753157303

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 17, 2026